數位生物標記市場規模、佔有率及成長分析（按類型、臨床實踐、治療領域、最終用戶和地區）—2025-2032 年產業預測

2023 年全球數位生物標記市場規模價值 39 億美元，預計將從 2024 年的 50.2 億美元成長到 2032 年的 380.5 億美元，預測期內（2025-2032 年）的複合年成長率為 28.8%。

由於醫療技術的快速進步、醫療成本的上升以及對遠距護理服務和遠端患者監護的需求不斷增加，數位生物標記市場正在經歷強勁成長。推動這一市場的關鍵因素包括對分散臨床試驗的投資增加、治療應用數量的增加以及穿戴式設備的普及和智慧型手機的廣泛普及。能夠檢測呼吸、聲音、溫度和眼球運動等重要指標的創新技術可以實現對複雜疾病的即時監測。值得注意的是，語音數位生物標記物具有巨大的成長機會。盧森堡健康研究所的 CoLive Voice 等措施凸顯了遠距風險評估和疾病管理的潛力。隨著越來越多的消費者採用智慧型手錶和健身追蹤器，市場有望繼續擴張。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術分析

數位生物標記市場規模（按類型）

• 市場概覽
• 穿戴式裝置
• 基於行動的應用程式
• 感應器
• 其他

按臨床實踐分類的數位生物標記市場規模

• 市場概覽
• 診斷數位生物標記
• 監測數位生物標記
• 預測和預後數位生物標記物
• 其他

按治療領域分類的數位生物標記市場規模

• 市場概覽
• 心血管和代謝疾病（CVMD）
• 呼吸系統疾病
• 精神障礙
• 睡眠和運動障礙
• 神經系統疾病
• 肌肉骨骼疾病
• 其他

按最終用戶分類的數位生物標記市場規模

• 市場概覽
• 醫療保健公司
• 醫療保健提供者
• 付款人
• 其他

數位生物標記市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• BioSensics（United States）
• AliveCor（United States）
• BACtrack（United States）
• Eyenuk（United States）
• Quibim（Spain）
• Biofourmis（United States）
• Fitbit（United States）
• Evidation Health（United States）
• Empatica（United States）
• Philips Healthcare（Netherlands）
• Medtronic（Ireland）
• Akili Interactive（United States）
• Apple Inc.（United States）
• Biotricity（United States）
• Tempus（United States）
• Pear Therapeutics（United States）
• BioBeats（United Kingdom）
• Oura Health（Finland）
• ActiGraph（United States）
• Koneksa（United States）

結論和建議

Global Digital Biomarkers Market size was valued at USD 3.9 billion in 2023 and is poised to grow from USD 5.02 billion in 2024 to USD 38.05 billion by 2032, growing at a CAGR of 28.8% during the forecast period (2025-2032).

The digital biomarkers market is experiencing robust growth, driven by rising demand for telecare services and remote patient monitoring, alongside rapid advancements in healthcare technology and increased healthcare expenditure. Key factors propelling this market include growing investments in decentralized clinical trials, expanding therapeutic applications, and the surge in wearable devices amid widespread smartphone usage. Innovative technologies capable of detecting vital indicators such as breathing, voice, heat, and eye movements are enabling real-time monitoring of complex diseases. Notably, vocal digital biomarkers present significant growth opportunities. Initiatives like the CoLive Voice by the Luxembourg Institute of Health highlight the potential for remote risk assessment and disease management. With an increasing number of consumers utilizing smartwatches and fitness trackers, the market is poised for continued expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Biomarkers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Biomarkers Market Segments Analysis

Global Digital Biomarkers Market is segmented by Type, Clinical Practice, Therapeutic Area, End Users and region. Based on Type, the market is segmented into Wearable, Mobile based Applications, Sensors and Others. Based on Clinical Practice, the market is segmented into Diagnostic digital biomarkers, Monitoring digital biomarkers, Predictive and Prognostic digital biomarkers and Others. Based on Therapeutic Area, the market is segmented into Cardiovascular and metabolic disorders (CVMD), Respiratory disorders, Psychiatric disorders, Sleep & Movement Disease, Neurological disorders, Musculoskeletal disorders and Others. Based on End Users, the market is segmented into Healthcare companies, Healthcare Providers, Payers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Biomarkers Market

The rise in the prevalence of diabetes, hypertension, and cardiovascular diseases is driving the demand for digital biomarkers. These advanced health indicators provide essential insights that enable healthcare systems to respond promptly and maintain continuous monitoring of chronic conditions. By facilitating optimal management practices, digital biomarkers empower patients to maintain their health for extended periods and minimize hospital visits. This proactive approach not only enhances patients' quality of life but also helps reduce overall healthcare costs. Consequently, the increasing focus on managing chronic illnesses is significantly fueling the global market for digital biomarkers, highlighting their importance in modern healthcare.

Restraints in the Global Digital Biomarkers Market

While digital biomarkers show significant potential, a major challenge lies in their lack of clinical validation, which is essential for their widespread acceptance among medical professionals. Due to insufficient rigorous research to establish their effectiveness in real-world applications, concerns regarding their accuracy and reliability are prevalent. This gap in validation hinders the broader acceptance and integration of digital biomarkers into standard treatment protocols, as healthcare providers prefer to utilize evidence-based tools that have proven efficacy. Consequently, the limited clinical validation of these biomarkers may impede their ability to gain traction in routine medical practice, posing a significant restraint in the global digital biomarkers market.

Market Trends of the Global Digital Biomarkers Market

The Global Digital Biomarkers market is witnessing a significant trend towards the integration of artificial intelligence (AI), which enhances the capability of wearables and health applications to generate data. By employing advanced AI algorithms to analyze and interpret this data, healthcare providers can uncover patterns and insights that might not be readily apparent, leading to more proactive and individualized healthcare approaches. This trend is pivotal in improving illness management and optimizing patient outcomes, as it amplifies the predictive power of digital biomarkers. Consequently, the market is positioned for robust growth, driven by the increasing reliance on technology for personal health monitoring and disease management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Digital Biomarkers Market Size by Type & CAGR (2025-2032)

• Market Overview
• Wearable
• Mobile based Applications
• Sensors
• Others

Global Digital Biomarkers Market Size by Clinical Practice & CAGR (2025-2032)

• Market Overview
• Diagnostic digital biomarkers
• Monitoring digital biomarkers
• Predictive and Prognostic digital biomarkers
• Others

Global Digital Biomarkers Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Cardiovascular and metabolic disorders (CVMD)
• Respiratory disorders
• Psychiatric disorders
• Sleep & Movement Disease
• Neurological disorders
• Musculoskeletal disorders
• Others

Global Digital Biomarkers Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Healthcare companies
• Healthcare Providers
• Payers
• Others

Global Digital Biomarkers Market Size & CAGR (2025-2032)

• North America (Type, Clinical Practice, Therapeutic Area, End Users)
  • US
  • Canada
• Europe (Type, Clinical Practice, Therapeutic Area, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Clinical Practice, Therapeutic Area, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Clinical Practice, Therapeutic Area, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Clinical Practice, Therapeutic Area, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• BioSensics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AliveCor (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BACtrack (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eyenuk (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quibim (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biofourmis (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fitbit (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evidation Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Empatica (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akili Interactive (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apple Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotricity (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pear Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioBeats (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oura Health (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ActiGraph (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koneksa (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations